Protein-protein interactions between UDP-glucuronosyltransferase isozymes in rat hepatic microsomes

Biochemistry
Shin-ichi IkushiroTakashi Iyanagi

Abstract

The interactions between UDP-glucuronosyltransferase (UGT) isozymes, UGT1s and UGT2B1, in rat hepatic microsomes were investigated using an immunopurification technique with anti-peptide antibodies and a chemical cross-linking strategy. A 50 kDa protein coimmunopurified with UGT1s was identified as UGT2B1 by amino-terminal sequencing and immunodetection with anti-peptide antibody against UGT2B1. Evidence for direct interaction of UGT2B1 with UGT1s was obtained by the loss of UGT2B1 adsorption to immunoaffinity column in Gunn rat hepatic microsomes, which lack all UGT1 isozymes. When the microsomes were treated with the chemical cross-linking reagent 1,6-bis(maleimido)-hexane, a cross-linked product with an apparent molecular mass of 120-130 kDa was obtained that immunostained with antibodies against UGT1s and UGT2B1, indicating the formation of a heterodimer containing one of the UGT1 isozymes and UGT2B1. The effects of UGT complex formation on the stimulation of glucuronidation of testosterone and uptake of UDP-glucuronic acid (UDP-GlcUA) by UDP-N-acetylglucosamine (UDP-GlcNAc) were examined. Alkaline pH-induced dissociation of the complexes was associated with the loss of UDP-GlcNAc-dependent stimulation of glucuronidation, s...Continue Reading

Citations

Apr 6, 2012·European Journal of Drug Metabolism and Pharmacokinetics·Jean-Marie HeydelYves Artur
Mar 19, 2013·The International Journal of Biochemistry & Cell Biology·Andrew RowlandPeter I Mackenzie
May 16, 2002·Biochimica Et Biophysica Acta·Claire SenaySylvie Fournel-Gigleux
Nov 11, 1998·General Pharmacology·F Guéraud, A Paris
Sep 28, 1998·Biochimica Et Biophysica Acta·T IyanagiS Ikushiro
Jan 28, 2004·Annual Review of Pharmacology and Toxicology·John O MinersPeter I Mackenzie
Jul 24, 2013·Biological & Pharmaceutical Bulletin·Yoshihisa KatoMasakuni Degawa
Nov 27, 1999·Drug Metabolism Reviews·A Radominska-PandyaP I Mackenzie
Jan 7, 2004·Drug Metabolism Reviews·Mohamed OuzzineSylvie Fournel-Gigleux
Mar 3, 2010·Expert Opinion on Drug Metabolism & Toxicology·Javier Conde-VancellsJuan M Falcon-Perez
Mar 24, 2015·Expert Opinion on Drug Metabolism & Toxicology·Zoe Riches, Abby C Collier
Oct 8, 2009·Drug Metabolism Reviews·Jacques MagdalouMohamed Ouzzine
Oct 13, 2009·Drug Metabolism Reviews·Yuji IshiiHideyuki Yamada
Oct 23, 2009·Drug Metabolism Reviews·Shinichi Ikushiro
Oct 28, 2009·Drug Metabolism Reviews·Chantal GuillemetteVincent Menard
May 29, 2009·Journal of Pharmaceutical Sciences·Ryoichi FujiwaraTsuyoshi Yokoi
May 17, 2011·Toxicology and Applied Pharmacology·Yoshihisa KatoMasakuni Degawa
Oct 12, 2010·Toxicology and Applied Pharmacology·Yoshihisa KatoMasakuni Degawa
Aug 5, 2005·Proteins·Oleg M AlekseevMichael G O'Rand
Nov 21, 2007·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Emi AkizawaOsamu Koiwai
Dec 26, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Eric LévesqueChantal Guillemette
Jun 24, 2003·Biochemical Pharmacology·Viviana A CataniaAldo D Mottino
Jun 2, 2006·Biochemical and Biophysical Research Communications·Kazuharu OkamuraHideyuki Yamada
May 13, 2010·Drug Metabolism and Pharmacokinetics·Yuji IshiiHideyuki Yamada
Jul 24, 1998·Biochemical and Biophysical Research Communications·M BeaulieuA Bélanger
May 1, 2007·Biochimica Et Biophysica Acta·Miklós CsalaGábor Bánhegyi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.